Risk management for analytical methods: conciliating objectives of methods, validation phase and routine decision rules
| dc.creator | Maumy, Myriam | |
| dc.creator | Boulanger, B. | |
| dc.creator | Dewe, W. | |
| dc.creator | Gilbert, A. | |
| dc.creator | Govaerts, B. | |
| dc.date | 2007-12-31 | |
| dc.date.accessioned | 2026-07-07T08:52:01Z | |
| dc.date.available | 2026-07-07T08:52:01Z | |
| dc.description | In the industries that involved either chemistry or biology, such as pharmaceutical industries, chemical industries or food industry, the analytical methods are the necessary eyes and hear of all the material produced or used. If the quality of an analytical method is doubtful, then the whole set of decision that will be based on those measures is questionable. For those reasons, being able to assess the quality of an analytical method is far more than a statistical challenge; it's a matter of ethic and good business practices. Many regulatory documents have been releases, primarily ICH and FDA documents in the pharmaceutical industry (FDA, 1995, 1997, 2001) to address that issue. | |
| dc.identifier | https://arxiv.org/abs/0801.0207 | |
| dc.identifier | http://arxiv.org/abs/0801.0207 | |
| dc.identifier | Dans Actes du congrès de Chimiométrie 2005 - Risk management for analytical methods: conciliating objectives of methods, validation phase and routine decision rules., France (2005) | |
| dc.identifier.uri | http://salesiana.dossiersoluciones.com/handle/123456789/145137 | |
| dc.subject | Applications | |
| dc.subject | Statistics Theory | |
| dc.title | Risk management for analytical methods: conciliating objectives of methods, validation phase and routine decision rules | |
| dc.type | text |